Medtronic's EV ICD System Proves Effective in Cardiac Arrhythmia Management: Long-term Study Results
Portfolio Pulse from Vandana Singh
Medtronic announced longer-term follow-up results of its investigational Extravascular Implantable Cardioverter Defibrillator (EV ICD) System, designed to treat dangerously fast heart rhythms. The study found that 6.8% of patients experienced appropriate therapy by 18 months, with a 100% success rate in terminating treated shocks.
May 22, 2023 | 5:58 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Medtronic's EV ICD System shows promising long-term results in managing cardiac arrhythmia, potentially boosting the company's product portfolio.
The positive long-term results of Medtronic's EV ICD System indicate its effectiveness in managing cardiac arrhythmia. This could lead to increased demand for the product, strengthening Medtronic's product portfolio and potentially having a positive impact on its stock price in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100